Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
BRIACELL THERAP (BCTX) had Cash Flow from Financial Activities of $31.89M for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-6.13M |
|
-- |
|
-- |
|
$6.33M |
|
$-6.33M |
|
$0.10M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.33M |
|
$-6.30M |
|
3.74M |
|
3.74M |
|
$-1.64 |
|
$-1.64 |
|
| Balance Sheet Financials | |
$14.79M |
|
$0.32M |
|
$2.22M |
|
$17.00M |
|
$4.33M |
|
-- |
|
$0.73M |
|
$5.06M |
|
$11.94M |
|
$11.94M |
|
$11.94M |
|
6.56M |
|
| Cash Flow Statement Financials | |
$-20.04M |
|
$-0.26M |
|
|
Cash Flow from Financial Activities |
$31.89M |
$0.86M |
|
$12.46M |
|
$11.60M |
|
$0.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.13% |
|
-52.13% |
|
-36.61% |
|
-52.13% |
|
$1.82 |
|
$-5.36 |
|
$-5.36 |
|